Nanobodies: natural single-domain antibodies
- PMID: 23495938
- DOI: 10.1146/annurev-biochem-063011-092449
Nanobodies: natural single-domain antibodies
Abstract
Sera of camelids contain both conventional heterotetrameric antibodies and unique functional heavy (H)-chain antibodies (HCAbs). The H chain of these homodimeric antibodies consists of one antigen-binding domain, the VHH, and two constant domains. HCAbs fail to incorporate light (L) chains owing to the deletion of the first constant domain and a reshaped surface at the VHH side, which normally associates with L chains in conventional antibodies. The genetic elements composing HCAbs have been identified, but the in vivo generation of these antibodies from their dedicated genes into antigen-specific and affinity-matured bona fide antibodies remains largely underinvestigated. However, the facile identification of antigen-specific VHHs and their beneficial biochemical and economic properties (size, affinity, specificity, stability, production cost) supported by multiple crystal structures have encouraged antibody engineering of these single-domain antibodies for use as a research tool and in biotechnology and medicine.
Similar articles
-
Introduction to heavy chain antibodies and derived Nanobodies.Methods Mol Biol. 2012;911:15-26. doi: 10.1007/978-1-61779-968-6_2. Methods Mol Biol. 2012. PMID: 22886243 Review.
-
Antibody repertoire development in camelids.Dev Comp Immunol. 2006;30(1-2):187-98. doi: 10.1016/j.dci.2005.06.010. Dev Comp Immunol. 2006. PMID: 16051357 Review.
-
Nanobodies: From Serendipitous Discovery of Heavy Chain-Only Antibodies in Camelids to a Wide Range of Useful Applications.Methods Mol Biol. 2022;2446:3-17. doi: 10.1007/978-1-0716-2075-5_1. Methods Mol Biol. 2022. PMID: 35157266
-
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies.Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4586-91. doi: 10.1073/pnas.0505379103. Epub 2006 Mar 13. Proc Natl Acad Sci U S A. 2006. PMID: 16537393 Free PMC article.
-
Single domain camel antibodies: current status.J Biotechnol. 2001 Jun;74(4):277-302. doi: 10.1016/s1389-0352(01)00021-6. J Biotechnol. 2001. PMID: 11526908 Review.
Cited by
-
Identification and characterization of nanobodies specifically against African swine fever virus major capsid protein p72.Front Microbiol. 2022 Oct 13;13:1017792. doi: 10.3389/fmicb.2022.1017792. eCollection 2022. Front Microbiol. 2022. PMID: 36312984 Free PMC article.
-
Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano).Front Oncol. 2020 Sep 11;10:1699. doi: 10.3389/fonc.2020.01699. eCollection 2020. Front Oncol. 2020. PMID: 33042812 Free PMC article.
-
Non-invasive strategy: Developing a topical IL-4Rα-specific nanobody for the treatment of allergic airway diseases.Mater Today Bio. 2024 Jul 8;27:101148. doi: 10.1016/j.mtbio.2024.101148. eCollection 2024 Aug. Mater Today Bio. 2024. PMID: 39108557 Free PMC article.
-
A Diverse Set of Single-domain Antibodies (VHHs) against the Anthrax Toxin Lethal and Edema Factors Provides a Basis for Construction of a Bispecific Agent That Protects against Anthrax Infection.J Biol Chem. 2016 Oct 7;291(41):21596-21606. doi: 10.1074/jbc.M116.749184. Epub 2016 Aug 18. J Biol Chem. 2016. PMID: 27539858 Free PMC article.
-
Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies.J Hematol Oncol. 2021 Apr 16;14(1):63. doi: 10.1186/s13045-021-01075-5. J Hematol Oncol. 2021. PMID: 33863363 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
